HOME >> BIOLOGY >> NEWS
More useful plants may sprout from gene role discovery

WEST LAFAYETTE, Ind. - It may be possible to alter plants so they are more nutritious and easier to process without weakening them so much they fall over, according to Purdue University researchers who found a new twist in a plant formation biochemical pathway.

Decreasing the amount of two acids in plant cell walls may enhance livestock feed digestibility for better nutrition, while increasing the potential uses of various plants, said Clint Chapple, Purdue biochemistry professor.

The findings, published in a recent issue of The Plant Cell, revise scientific thinking about the role of ferulic and sinapic acids in building plant cell walls. For many years, researchers believed that the two acids contributed to the production of lignin, the principal structural component of plant cell walls.

"It's the hardening substance that makes the difference between a piece of celery and a piece of wood," Chapple said.

Based on laboratory studies, Chapple and his team found that an enzyme converts two molecules into the acids, which then are incorporated into cell walls. This indicates that sinapic and ferulic acids are end products rather than intermediates, or building blocks, in an essential biochemical pathway for cell wall construction, Chapple said.

"Now that we know the acids are not part of the lignin pathway, it may be possible to change cell walls without harming the plant," he said. "It will be easy to isolate and alter the corresponding gene in other plants, including those used for livestock feed such as corn."

The main focus of the research is to create more useful plants. In normal plants, cross linking of lignin, ferulic acid and other substances forms a strong bond that make cell walls difficult to break down.

But Chapple said he believes that cell walls could be manipulated so that nutrients in livestock feed are more easily absorbed into the digestive tract.

One clue that led Chapple's team to its
'"/>

Contact: Susan A. Steeves
ssteeves@purdue.edu
765-496-7481
Purdue University
19-Apr-2004


Page: 1 2 3

Related biology news :

1. Grape seed extract may be useful supplement to blunt hypertension in postmenopausal women
2. Preventing cancer: Scientists identify a useful piece of JNK
3. U-Iowa scientists gain insight on how enzyme uses oxygen to produce useful chemicals
4. First potentially clinically useful independent marker for lung cancer identified
5. Study identifies new protein on neurons that may be useful as survival/growth factor
6. E. coli bacteria may be more useful than you think
7. New N.C. ferry-linked water monitoring begins generating useful data for analysis
8. Asprin-like drugs may be useful for cancer treatment, study suggests
9. Experts say independent scientific panels useful in advising judges in complex cases
10. Magnetic resonance imaging of sexual intercourse is both possible and useful...
11. Inhaled drug useful in preventing flu

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: More useful plants may sprout from gene role discovery

(Date:12/10/2014)... 08, 2014 Research and Markets ... the "Biometrics Market in Japan 2014-2018" ... http://photos.prnewswire.com/prnh/20130307/600769 The integration of ... rural banking and upgradation of the driver,s license ... the market. Besides the aforementioned projects, biometrics is ...
(Date:12/5/2014)... 2014 Increased emphasis on product quality, ... testing and inspection technologies. The convergence of industries ... range of innovative test solutions. This trend is ... which is generally more inclined towards communication, media ... strategies of test equipment vendors will cater to ...
(Date:12/4/2014)... 3, 2014  Crossmatch™, a leading provider of ... DigitalPersona ® Pro Enterprise software and U.are.U ... throughout First Bank branch locations in ... and Virginia. First Bank, a progressive community ... North Carolina , selected the Crossmatch biometrics-based ...
Breaking Biology News(10 mins):Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
(Date:12/19/2014)... YORK , Dec. 18, 2014 Relmada ... therapies for the treatment of chronic pain, announced the ... today. "This was a transformational year in ... promising future for our company," said Sergio Traversa ... year, we have executed on key financial, human resource ...
(Date:12/17/2014)... N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today announced ... (referred to as Somatuline®) was approved by the ... treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in adult ... advanced or metastatic disease to improve progression-free survival ...
(Date:12/17/2014)... 17, 2014 Audacity, a leading California-based ... member of the Huntsworth Health Group, is proud to ... team. In her role, Gonzales will serve as Senior ... incredibly honored to welcome a talent of Jamie’s caliber ... Gaëtan Fraikin. “She is a proven healthcare innovation leader ...
(Date:12/17/2014)... Mass. , Dec. 17, 2014   Synageva ... biopharmaceutical company developing therapeutic products for rare disorders, announced ... Conference being held in San Francisco, CA. ... President and Chief Executive Officer, will present on Monday, ... EST).  The presentation will be webcast live and may ...
Breaking Biology Technology:Relmada Therapeutics Announces Results of Annual Shareholders Meeting 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Audacity Welcomes Healthcare Communications Expert Jamie Gonzales as Senior Vice President of Client Services 2
Cached News: